Scribe Therapeutics Q3 EPS $(0.68) Beats $(2.06) Estimate, Sales $1.600M Miss $3.113M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(2.06) by 66.99 percent. The company reported quarterly sales of $1.600 million which
Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(2.06) by 66.99 percent. The company reported quarterly sales of $1.600 million which missed the analyst consensus estimate of $3.113 million by 48.60 percent.